142 related articles for article (PubMed ID: 6727279)
1. Non-additive positive inotropic effects of amrinone and ouabain on cat papillary muscles.
Brown L; Erdmann E
Klin Wochenschr; 1984 May; 62(9):390-3. PubMed ID: 6727279
[TBL] [Abstract][Full Text] [Related]
2. Concentration-response curves of positive inotropic agents before and after ouabain pretreatment.
Brown L; Erdmann E
Cardiovasc Res; 1985 May; 19(5):288-98. PubMed ID: 3995524
[TBL] [Abstract][Full Text] [Related]
3. Developmental changes in the interactions of amrinone and ouabain in canine ventricular muscle.
Binah O; Rosen MR
Dev Pharmacol Ther; 1983; 6(5):333-46. PubMed ID: 6628165
[TBL] [Abstract][Full Text] [Related]
4. Responses to amrinone in isolated cardiac muscles from cat, rabbit, and guinea pig.
Siegl PK; Morgan G; Sweet CS
J Cardiovasc Pharmacol; 1984; 6(2):281-7. PubMed ID: 6200717
[TBL] [Abstract][Full Text] [Related]
5. Effects of amrinone on contraction and K+-induced contracture of normal and subacutely failed cat ventricular muscle.
Gaide MS; Kimura S; Lodge NJ; Cameron JS; Kozlovskis PL; Myerburg RJ; Bassett AL
Circulation; 1986 Mar; 73(3 Pt 2):III36-45. PubMed ID: 3943180
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis for the cardiovascular activities of amrinone and AR-L57.
Hayes JS; Bowling N; Boder GB; Kauffman R
J Pharmacol Exp Ther; 1984 Jul; 230(1):124-32. PubMed ID: 6086873
[TBL] [Abstract][Full Text] [Related]
7. Enhanced relaxation and reduced positive inotropic effects of amrinone in ventricular muscle from cats with subacute heart failure. Implications for drug therapy.
Bassett AL; Gaide MS; Lodge NJ; Cameron JS
Adv Myocardiol; 1985; 6():629-36. PubMed ID: 2986264
[TBL] [Abstract][Full Text] [Related]
8. Positive inotropic action of amrinone: effect of elevated external Ca2+.
Rendig SV; Amsterdam EA
J Cardiovasc Pharmacol; 1984; 6(2):293-9. PubMed ID: 6200719
[TBL] [Abstract][Full Text] [Related]
9. Chronotropic and inotropic actions of amrinone, carbazeran and isobutylmethyl xanthine: role of phosphodiesterase inhibition.
Shahid M; Rodger IW
Br J Pharmacol; 1989 Sep; 98(1):291-301. PubMed ID: 2478244
[TBL] [Abstract][Full Text] [Related]
10. Cardiotonic and coronary vasodilatatory effects of amrinone in the canine heart-lung preparation with a support dog as compared with those of dobutamine.
Takeda K; Matsui K; Nakazawa M; Nakahara H; Imai H; Imai S
Jpn J Pharmacol; 1986 Mar; 40(3):381-8. PubMed ID: 3012165
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the cardiotonic effects of milrinone, a new and potent cardiac bipyridine, on isolated tissues from several animal species.
Alousi AA; Stankus GP; Stuart JC; Walton LH
J Cardiovasc Pharmacol; 1983; 5(5):804-11. PubMed ID: 6195468
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of the bipyridines: amrinone and milrinone.
Alousi AA; Johnson DC
Circulation; 1986 Mar; 73(3 Pt 2):III10-24. PubMed ID: 2417744
[TBL] [Abstract][Full Text] [Related]
13. Cardiac effects of amrinone on rabbit papillary muscle and guinea pig Langendorff heart preparations.
Onuaguluchi G; Tanz RD
J Cardiovasc Pharmacol; 1981; 3(6):1342-55. PubMed ID: 6173535
[TBL] [Abstract][Full Text] [Related]
14. Electrical and mechanical effects of amrinone on isolated guinea pig ventricular muscle.
Kondo N; Shibata S; Kodama I; Yamada K
J Cardiovasc Pharmacol; 1983; 5(6):903-12. PubMed ID: 6196561
[TBL] [Abstract][Full Text] [Related]
15. [Effects of amrinone on isolated heart preparations: comparative study with other inotropic agents].
Raddino R; Metra M; Catellani E; Nodari S; Pelà G; Manca C; Dei Cas L
Cardiologia; 1991 Sep; 36(9):729-34. PubMed ID: 1686991
[TBL] [Abstract][Full Text] [Related]
16. Additive positive inotropic effects of milrinone, ouabain and calcium in diseased human ventricular myocardium.
Brown L; Näbauer M; Erdmann E
Klin Wochenschr; 1986 Aug; 64(15):708-12. PubMed ID: 3762018
[TBL] [Abstract][Full Text] [Related]
17. Positive inotropic effect of amrinone in relation to cyclic nucleotide metabolism in the canine ventricular muscle.
Endoh M; Yamashita S; Taira N
J Pharmacol Exp Ther; 1982 Jun; 221(3):775-83. PubMed ID: 6283063
[TBL] [Abstract][Full Text] [Related]
18. Amrinone. A preliminary review of its pharmacological properties and therapeutic use.
Ward A; Brogden RN; Heel RC; Speight TM; Avery GS
Drugs; 1983 Dec; 26(6):468-502. PubMed ID: 6360634
[TBL] [Abstract][Full Text] [Related]
19. Inotropic effects of amrinone and milrinone on contraction and relaxation of isolated cardiac muscle.
Sys SU; Goenen MJ; Chalant CH; Brutsaert DL
Circulation; 1986 Mar; 73(3 Pt 2):III25-35. PubMed ID: 3002662
[TBL] [Abstract][Full Text] [Related]
20. A report on the positive inotropic action of amrinone.
Cargnelli G; Padrini R; Piovan D; Piacenza G; Ferrari M; Gallucci V
Boll Soc Ital Biol Sper; 1982 Jul; 58(13):793-9. PubMed ID: 7126350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
